Drug Delivery:

Content Related to Drug Delivery



• Multiparticulate Drug Delivery Systems Multiparticulates or multiple unit dosage forms are the discrete, small, repetitive units of drug particles which may or may not possess similar drug release pattern.  They can be tailored for pulsatile, controlled and or delayed, targeted drug release depending upon the polymer employed in fabrication. A blend of multiparticulates can also be used to provide the desired drug release profile.&nbs....Read more

  Contributor:  T. E. Gopala Krishna Murthy Tags: T. E. Gopala Krishna Murthy | multiparticulate drug delivery systems | drug delivery systems 10/04/2010  12:00:00 AM EDT

• Applying Biopharmaceutical Nanotechnology to Diagnostics, Drug Discovery and Drug Delivery The application of nanobiotechnology has far ranging uses within a number of sectors of the life sciences industry, including drug discovery, formulation, clinical assessment, drug delivery and monitoring. A benchmark report on nanotechnology produced in 2002 by CMP Cientifica claimed that nanotechnology will have "a major impact on the medical and pharmaceuticals industry" and since then ....Read more

  Contributor:  Pharma IQ Tags: nanotechnology | biopharmaceutical nanotechnology | nano 08/12/2010  12:00:00 AM EDT

• Three Top Tips for Evaluating the Potential of New Drug Delivery Technologies Dr. Keith Horspool, Vice President, Pharmaceutical Development US at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ, to discuss strategies to reduce time spent in R&D and recent trends in the adoption of novel drug delivery technologies. Pharma IQ: How has the global market for pharmaceutical R&D evolved in recent years? K Horspool: Clearly it’s a much tougher envi....Read more

  Contributor:  Keith Horspool Tags: Keith Horspool | Boehringer Ingelheim | pharmaceutical development 03/25/2011  12:00:00 AM EDT

• 	Post Show Survey: Global Formulation & Drug Delivery Summit 2013 Create your free online surveys with SurveyMonkey , the world's leading questionnaire tool.....Read more
  Contributor:  Pharma IQ Surveys Tags: Post Show Survey Global Formulation & Drug Delivery Summit 2013 | Global Formulation & Drug Delivery Summit 2013 | Global Formulation & Drug Delivery Summit 2013 Feedback 05/02/2013  12:00:00 AM EDT

• Drug Delivery Processes Look to Technology for Improvements As with any industry, pharmaceutical firms are always looking for ways to improve drug formulation and delivery in order to enhance customer experience as well as cut costs and streamline processes. It is also hoped that by working on these areas, market leaders can cut the length of time it takes to get drugs on shelves and, ultimately, treating those who need them. However, there are two main stum....Read more

  Contributor:  Pharma IQ Tags: drug delivery | formulation | drug delivery processes 11/30/2011  12:00:00 AM EST

• Utilising Solubility Modelling to Reduce the R&D Timeline Reducing the time drugs take to get to market is a key focus for a pharmaceutical industry facing the expiry of patents on blockbuster products and the subsequent influx of generics. Poor solubility is one of the ever-present factors delaying drug development and it would appear current industry conditions have led pharmaceutical companies to step up investment to combat this. Indeed, improving....Read more

  Contributor:  Pharma IQ Tags: solubility | reformulating products | generics 12/24/2010  12:00:00 AM EST

• In Demand: Prefilled Syringes The prefilled syringes sector has witnessed healthy growth in recent years and demand is expected to rise. This is due to the increased number of injectable biological drugs in the pipeline and healthcare professionals and patients demanding safer more convenient drugs, devices and delivery systems. According to a recent iRAP report, PH-1 Nano-Enabled Packaging for the Pharm....Read more

  Contributor:  Andrea Charles Tags: prefilled syringes | pre-filled syringes | pharmaceutical packaging 09/14/2010  12:00:00 AM EDT

• 	Predictions for Targeted Drug Delivery with David Elder and Brendan Griffin In this Pharma IQ interview David Elder, Director of Product Development, GlaxoSmithKline and Brendan Griffin Lecturer in Pharmaceutics and Course Director University College Cork, discuss how they are tackling major challenges in drug development, such as improving solubility to enhance
  Contributor:   Andrea Charles Tags: David Elder | Brendan Griffin | GSK 12/05/2011  12:00:00 AM EST

• 	Why Changes are needed to Current Preformulation and Formulation Practices As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ , about why changes are needed to current preformulation and formulation practices, strategies to reduce time spent in R&D
  Contributor:   Andrea Charles Tags: Keith Horspool | Boehringer Ingelheim | co-crystals 03/15/2011  12:00:00 AM EDT

• 	Nanocluster Technology and Microcapsule Approaches: Two New Drug Delivery Mechanisms New techniques for developing drug delivery mechanisms have led to two new particle engineering approaches that offer unique formula opportunities. Dr. Cory Berkland, Associate Professor at the University of Kansas, joins Amber Scorah from Pharma IQ, to talk about nanocluster technology and
  Contributor:   Amber Scorah Tags: Cory Berkland | University of Kansas | nanocluster technology 01/17/2011  12:00:00 AM EST

• 	Delivering Patient Compliance Through User Focused Development of Delivery Systems Tim Chesworth, Team Manager - Packaging & Devices at  AstraZeneca, joins Andrea Charles from Pharma IQ, to speak about delivering patient compliance through user focused development of delivery systems. Chesworth discusses the key drivers of the pre-filled syringes and injectable
  Contributor:   Andrea Charles Tags: Tim Chesworth | pre-filled syringes | injectable technology 12/20/2010  12:00:00 AM EST

• Joël Richard VP, Peptides for Ipsen on Formulation Challenges for Biological Drug Products In this industry interview Joël Richard Vice President, Peptides for Ipsen, speaks to Andrea Charles from Pharma IQ, about formulation challenges for biological drug products. Pharma IQ: Can you briefly explain your current role and responsibilities? J Richard: I'm presently the Vice-President, Peptides, for Ipsen, which means that I'm leading all the activities that are called CMC ....Read more

  Contributor:  Joël Richard Tags: Joël Richard | Ipsen | peptides 02/04/2013  12:00:00 AM EST

• Implementing Thermal Processing Technologies for the Production of Amorphous Solid Dispersions Amorphous pharmaceutical materials are now being recognised as an attractive alternative route for solid state development. Dr. Dave Miller, Senior Principal Scientist at Hoffmann-La Roche, speaks to Helen Winsor from Pharma IQ, about the challenges of amorphous solid dispersion production, and explores formulation design principles for thermally processed amorphous systems. To listen to the podc....Read more

  Contributor:  Helen Winsor Tags: Dave Miller | amorphous solid dispersion production | amorphous materials 09/06/2010  12:00:00 AM EDT

• 3 Tips on Overcoming Poor Aqueous Solubility and Stability   What are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Rene Holm, Head of Preformulation at H Lundbeck A/S, joins Pharma IQ to discuss the benefits of early stage preformulation, how advances in drug delivery devices have impacted on formulations, and strategies for enhancing solubility. ....Read more

  Contributor:  Helen Winsor Tags: Rene Holm | Lundbeck | formulation 02/15/2011  12:00:00 AM EST

• 	Safety Assessment of Novel Respiratory Delivery Systems: Lessons from the Exubera® Development Program
  Tags: John Teeter | novel drug delivery | respiratory delivery systems

• Optimising the Development of Protein Formulations The pharmaceutical industry constantly sees the need to develop a marketable and safe protein drugs for mainstream human use as an important issue. However, there are many challenges which surround such a vision and make protein formulation particularly problematic. Perhaps one of the largest of these barriers that needs to be overcome in order to make sure that protein drugs can....Read more

  Contributor:  Pharma IQ Tags: protein formulations | formulation development | protein therapeutic 07/17/2012  12:00:00 AM EDT

• Buccal Delivery: Simple Physical Chemical Considerations Efficient treatments options that are acceptable for both the patients and the physicians are the corner stones in drug development within the pharmaceutical industry. Oral administration is the preferred route of administration as this route is normally associated with the highest patient compliance, what novel drug delivery systems must offer in particular better therapeutic outcomes compared to e....Read more

  Contributor:   Tags: Drug Delivery | Buccal Delivery 09/05/2012  12:00:00 AM EDT

• Self-Assembling Peptide Formulations for Drug Delivery In this interview, Sotirios Koutsopoulos, Research Scientist at the Center for Biomedical Engineering at Massachusetts Institute of Technology, discusses the latest research in designer self-assembling peptides, injectable peptide hydrogel for targeted delivery of small drug compounds and proteins, and the direction of their future work.   Pharma IQ: Can you tell us about the latest r....Read more

  Contributor:  Pharma IQ Tags: drug delivery | designer self-assembling peptides | self-assembling peptides 07/10/2012  12:00:00 AM EDT

• The Search for New and Innovative Excipients – Possible Applications of Semi Fluorinated Alkanes A high proportion of the drug compounds in the innovative pharmaceutical companies have poor aqueous solubility or high metabolic ratio (Fahr and Liu, 2007; Hauss, 2007; Lipinski et al., 1997), which may limit their bioavailability after oral administration. This provides the pharmaceutical scientist with a general challenge to identify enabling technologies or alternative delivery routes, which ensures ....Read more

  Contributor:   Tags: SFA | drug delivery | René Holm 05/07/2013  12:00:00 AM EDT

• 	Successfully Acquiring a Biosimiliar in Drug Delivery for Partnering Pharma IQ interviews Christopher Slavinsky, Assistant General Council, Established Products Brand, Pfizer, Inc., who discusses how to successfully acquire a biosimiliar in drug delivery for partnering.
  Contributor:   Pharma IQ Tags: Christopher Slavinsky | drug delivery | biotech 04/27/2010  12:00:00 AM EDT

A glossary of keywords, acronyms and general terminology used in day-to-day professional work, Pharma. If you would like to add to, edit or comment on this page, please drop us a line at info@pharma-iq.com